Groundbreaking AI-driven diagnostic methods are emerging in oncology and disease management. The University of Sharjah developed AI models for early pancreatic cancer detection and prognosis prediction. Additionally, a terbium-based luminescent sensor for liver cancer biomarker β-glucuronidase showed high sensitivity. These innovations highlight the advancement of precision diagnostics based on AI and novel biosensors, promising earlier and more accurate disease identification.